Found: 14
Select item for more details and to access through your institution.
Kadcyla Approved for Adjuvant Treatment of HER2-Positive Early Breast Cancer with Residual Invasive Disease.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 7, p. 33
- Publication type:
- Article
Evolving Immuno-Oncology Strategies in Renal-Cell Carcinoma.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 7, p. 19
- By:
- Publication type:
- Article
Immunotherapy Moving into Earlier Lines of Lung Cancer Therapy.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 7, p. 17
- By:
- Publication type:
- Article
Piqray First PI3K Inhibitor Approved by the FDA for Metastatic Breast Cancer and PI3KCA Mutation.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 7, p. 33
- Publication type:
- Article
Call to Action: Greater Focus on Metastatic Cancer Survivors Is Needed.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 7, p. 30
- By:
- Publication type:
- Article
Osimertinib plus Savolitinib Promising for Non-Small-Cell Lung Cancer with MET-Driven Resistance.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 7, p. 28
- By:
- Publication type:
- Article
Infigratinib a Novel, Potent Selective TKI Targeting FGFR Fusions in Different Tumor Types.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 7, p. 26
- By:
- Publication type:
- Article
High Tumor Mutation Burden Predictive Biomarker for Survival in Metastatic Lung Cancer.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 7, p. 24
- By:
- Publication type:
- Article
Gilteritinib a New Standard of Care for Relapsed or Refractory AML with FLT3 Mutation.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 7, p. 22
- By:
- Publication type:
- Article
Revised Risk Categories in NCCN Guideline for Metastatic Renal-Cell Carcinoma Affects Preferred Front-Line Options.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 7, p. 8
- By:
- Publication type:
- Article
Oncology Reimbursement Reform: Changes on the Horizon.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 7, p. 16
- By:
- Publication type:
- Article
FDA Unveils Pilot Program to Expand Access to Investigational Oncology Drugs.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 7, p. 1
- By:
- Publication type:
- Article
New Targeted Therapies for Metastatic Colorectal Cancer Recommended in the Updated NCCN Guideline.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 7, p. 1
- By:
- Publication type:
- Article
Decision Time Is Approaching for Practices in the Oncology Care Model.
- Published in:
- Oncology Practice Management, 2019, v. 9, n. 7, p. 1
- By:
- Publication type:
- Article